Search results for "Lymph"

showing 10 items of 4590 documents

Reply

2017

Reply to a Letter to Editor

medicine.medical_specialtybusiness.industrySettore MED/19 - Chirurgia Plastica030230 surgerymedicine.diseaseLymphatic System03 medical and health sciencesLymphatic Vessel0302 clinical medicineLymphedema030220 oncology & carcinogenesismedicineSurgeryPostoperative PeriodRadiologyLymphatic functionbusinessHumanPlastic and Reconstructive Surgery
researchProduct

Longitudinal investigation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in older patients in the province of Palermo (So…

2020

IntroductionClinical presentation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in old adults from Southern Italy is little known. This study aims to investigate the mortality risk related to risk factors, therapy and clinical course and to suggest prognostic indicators based on day-to-day follow-up of clinical and laboratory findings.Material and methodsIt was designed as a retrospective longitudinal cohort study of adult SARS-CoV-2 patients admitted at Partinico COVID Hospital in Palermo, Southern Italy. Patients were recruited between 4 March and 25 April and followed up until 31 May 2020, day-to-day until death or hospital discharge. Clinical data, laboratory…

medicine.medical_specialtybusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)General Medicinechronic kidney failuremedicine.diseaseSettore MED/01 - Statistica MedicaChronic kidney failureOlder patientsdiabeteInternal medicineDiabetes mellitusD-dimerPandemicMedicineDementiaNeutrophils/Lymphocytes Ratiobusinessprognostic factordementiaArchives of medical science : AMS
researchProduct

2015

Objectives: Non-Hodgkin lymphomas are malignant neoplastic proliferations of the immune system that can manifest as nodal or extranodal lymphomas. The aim of this study was to retrospectively investigate the site of occurrence of lymphomas in the head and neck area and to analyze the typical symptoms of patients who presented at an oral and maxillofacial surgical department. Material and Methods: All patient files from1971 until 2012 from an Oral and Maxillofacial Surgery of a University were analyzed for the diagnosis non-Hodgkin lymphoma. Epidemiologic data and data regarding the localization of the malignant lymphoma were evaluated. Results: 62 patients, 34 women and 28 men with a non-Ho…

medicine.medical_specialtybusiness.industrySoft tissueRetrospective cohort studyGeneral Medicinemedicine.diseaseSingle CenterLymphomaSurgeryMalignant lymphomaimmune system diseaseshemic and lymphatic diseasesOral and maxillofacial surgerymedicineRadiologyEpidemiologic dataHead and neckbusinessInternational Journal of Medical Sciences
researchProduct

Chirurgische Therapie des Ösophaguskarzinoms: Eine prospektive 20-Jahres-Analyse

2008

BACKGROUND: The aim of our study was the analysis of long-term developments in the surgical therapy for esophageal carcinoma at our hospital over a period of 20 years with a differentiated view on the two predominant histological tumour types. PATIENTS AND METHODS: Between September 1985 and September 2005, esophageal resections were performed in 470 patients at our clinic on account of a malignant tumour of the esophagus. The abdomino-thoracic resection with abdominal and extended mediastinal lymph node dissection as well as intrathoracic anastomosis was the standard treatment in the case of squamous cell carcinoma, whereas in adenocarcinoma a transhiatal resection with abdominal and dorsa…

medicine.medical_specialtybusiness.industryStandard treatmentAnastomosismedicine.diseaseSurgeryStomach surgerymedicine.anatomical_structureMediastinal lymph nodeCarcinomamedicineAdenocarcinomaSurgeryEsophagusbusinessSurvival rateZentralblatt für Chirurgie
researchProduct

Extrahepatic Manifestations of Chronic HCV

2011

A number of extrahepatic manifestations have been reported in patients infected with HCV. The most prominent of theme are MC vasculitis, lymphoproliferative malignancies, renal disease, polyarthritis, thyroid and glucose disorders. Although these conditions might have a substantial impact on morbidity, patient management, and prognosis, for most of them the exact mechanisms underlying their development require further elucidation.

medicine.medical_specialtybusiness.industryThyroidDiseasemedicine.diseaseDermatologyNon-Hodgkin's lymphomaPatient managementmedicine.anatomical_structuremedicinePolyarthritisIn patientVasculitisbusinessB cell
researchProduct

Sonographische Charakteristika laterozervikaler Raumforderungen

2001

UNLABELLED Sonography of the head and neck mainly focuses on tumours of the lateral neck. Even though most of these masses are enlarged lymph nodes, other tumors have to be considered. AIM To determine whether different pathological cervical masses display a characteristic sonographic morphology. METHOD On the basis of 530 sonographical findings in the neck, typical ultrasound characteristics either in B-scan or in colour coded sonography were demonstrated. RESULTS Apart from enlarged lymph nodes, it was possible to differentiate other occurrences such as branchial cysts, abscesses, laryngoceles, lipomas, neurinomas, glomus tumours, paragangliomas and also fibromas by their specific ultraso…

medicine.medical_specialtybusiness.industryUltrasoundEarly detectionBranchial CystLateral neckCervical massesMedicineRadiology Nuclear Medicine and imagingLymphRadiologybusinessHead and neckPathologicalUltraschall in der Medizin
researchProduct

Cystic lymphangioma of the retroperitoneum

2000

medicine.medical_specialtybusiness.industryUrologyLymphangiomamedicineRadiologyCongenital diseasebusinessmedicine.diseaseSurgeryUrology
researchProduct

Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for…

2017

medicine.medical_specialtybusiness.industryUrologymedicine.medical_treatment030218 nuclear medicine & medical imagingSurgeryFunctional imagingRadiation therapy03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesismedicineRadiologybusinessLymph nodeEuropean Urology
researchProduct

Evaluation of Safety, Tolerability and Efficacy of Temsirolimus in Patients with Relapsed or Refractory Mantle Cell Lymphoma (REL/REFR MCL) in the Us…

2012

ABSTRACT Background Temsirolimus (TEMS), an mTOR-inhibitor, is approved the EU for the treatment of patients (pts) with relapsed or refractory MCL (rel/refr). A pivotal study demonstrated significantly longer progression free survival with TEMS (175mg weekly for 3 weeks followed by 75mg weekly) in rel/refr MCL pts compared to investigatoŕs choice therapy (4.8 mo vs 1.9 mo; P = .0009). To better identify safety and efficacy of TEMS in an unselected patient population during clinical routine a prospective non-interventional study with TEMS in rel/refr MCL-pts was started. Here we report on interim results of the study. Methods A registry for rel/refr MCL pts treated with TEMS was started in G…

medicine.medical_specialtybusiness.industrymacromolecular substancesHematologyTemsirolimusOncologyTolerabilityRefractoryInternal medicinemedicineRefractory Mantle Cell LymphomaIn patientProgression-free survivalLeukocytosismedicine.symptombusinessAdverse effectmedicine.drugAnnals of Oncology
researchProduct

Prior Treatment with Alemtuzumab Interferes with T-Cell Engraftment After Allogeneic Stem Cell Transplantation in Patients with Chronic Lymphocytic L…

2009

Abstract Abstract 3351 Poster Board III-239 Objectives: The majority of patients with chronic lymphocytic leukemia (CLL) who receive allogeneic hematopoietic cell transplantation (HCT) have fludarabine-refractory disease. The most active single agent in this disease stage is alemtuzumab. Alemtuzumab has a long half-life and induces profound T-cell depletion (TCD). Since TCD may mitigate graft-versus leukemia effects we evaluated „pre-conditioning“ with alemtuzumab followed by a washout period in order to minimize in vivo T-cell depletion of the graft in a phase II study (NCT 00337519). Methods: Patients received cytoreductive treatment with 3 × 30 mg alemtuzumab weekly prior to HCT. The sch…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentChronic lymphocytic leukemiaImmunologyCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryGastroenterologySurgeryFludarabineTransplantationInterquartile rangeInternal medicinemedicineAlemtuzumabbusinessProgressive diseaseBusulfanmedicine.drugBlood
researchProduct